
Venture capital · Est. 1976
Sofinnova
Sofinnova is a healthcare investment firm focused on therapeutic drug companies, investing in both private and public equity. It has offices in Menlo Park, Boston and New York.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Sofinnova right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
BetaRounds Sofinnova joined, from press and the firm’s own posts.
2 rounds in the last 12 months
Round sizes, Sofinnova’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Sofinnova backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Sofinnova
Events where Sofinnova’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Sofinnova is based in Menlo Park, United States. It also has offices in Boston and New York.
In 1976.
7 fund vehicles are on public registers (SEC adviser filings), including SOFINNOVA BIOEQUITIES ENHANCED MASTER FUND, LP, SOFINNOVA VENTURE PARTNERS IX, L.P. and SOFINNOVA VENTURE PARTNERS XI, L.P.
Sectors: Life sciences. From the firm’s own website.
Backs late preclinical and clinical-stage therapeutics companies in the US and Europe, led by a team of mostly doctors and PhDs. It supports entrepreneurs from drug development and regulatory navigation through company building and IPO, acting as a board-level partner. From the firm’s own website.
Sofinnova lists 31 portfolio companies on its website, including Claris Bio, City Therapeutics, Inc., Coultreon Biopharma, Expedition Therapeutics and ARTBIO, Inc..
Firms whose websites list some of the same companies include RA Capital, Catalio Capital Management and ARCH Venture Partners.
Know before Sofinnova’s next round is announced.
PRO tracks Sofinnova’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.